Skip to main content
# Title Research Member Research Year
161 Adjuvant Chemotherapy in High Risk Colon Cancer Standard FOLFOX or XELOX versus Short Duration of XELOX Dr. Mayada Fawzy Sedik Farghaly 2018
162 Signet ring carcinoma of the stomach: impact on prognosis and outcome
Dr. Hanaan Ahmed Mohammed Ahmed 2018
163 Adjuvant Chemotherapy in High Risk Colon Cancer Standard FOLFOX or XELOX versus Short Duration of XELOX Dr. Amen Hamdy Zaki Ali 2018
164 Tri-modalities for bladder cancer in elderly: Trans-urethral resection, hypofractionated radiotherapy and gemcitabine Dr. Adel Gomaa Mohamed Gabr 2018
165 Signet ring carcinoma of the stomach: impact on prognosis and outcome
Dr. Mayada Fawzy Sedik Farghaly 2018
166 Signet ring carcinoma of the stomach: impact on prognosis and outcome
Dr. Mayada Fawzy Sedik Farghaly 2018
167 Adjuvant Chemotherapy in High Risk Colon Cancer Standard FOLFOX or XELOX versus Short Duration of XELOX Dr. Mayada Fawzy Sedik Farghaly 2018
168 Retrospective study of sarcomas pattern and outcomes
in South Egypt Cancer Institute from 2005-2015
Amany Nasr Ahmed Mohammed Elemary 2018
169 1. Concurrent Use of Capecitabine with Adjuvant
Radiotherapy in the Treatment of Patients with Breast
Cancer
Dr. Hanaan Ahmed Mohammed Ahmed 2018
170 Adjuvant Chemotherapy in High Risk Colon Cancer Standard FOLFOX or XELOX versus Short Duration of XELOX Dr. Amen Hamdy Zaki Ali 2018